000 | 01618 a2200457 4500 | ||
---|---|---|---|
005 | 20250513061427.0 | ||
264 | 0 | _c19931004 | |
008 | 199310s 0 0 eng d | ||
022 | _a0105-4538 | ||
024 | 7 |
_a10.1111/j.1398-9995.1993.tb02410.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPedersen, B | |
245 | 0 | 0 |
_aThe effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X. _h[electronic resource] |
260 |
_bAllergy _cJul 1993 |
||
300 |
_a377-82 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAdrenergic beta-Agonists _xpharmacology |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlbuterol _xanalogs & derivatives |
650 | 0 | 4 | _aAllergens |
650 | 0 | 4 |
_aAsthma _xblood |
650 | 0 | 4 |
_aBlood Proteins _xanalysis |
650 | 0 | 4 | _aBronchial Provocation Tests |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aEosinophil Granule Proteins |
650 | 0 | 4 | _aEosinophil-Derived Neurotoxin |
650 | 0 | 4 | _aEosinophils |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aForced Expiratory Volume |
650 | 0 | 4 | _aHistamine |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLeukocyte Count |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRibonucleases |
650 | 0 | 4 | _aSalmeterol Xinafoate |
700 | 1 | _aDahl, R | |
700 | 1 | _aLarsen, B B | |
700 | 1 | _aVenge, P | |
773 | 0 |
_tAllergy _gvol. 48 _gno. 5 _gp. 377-82 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1398-9995.1993.tb02410.x _zAvailable from publisher's website |
999 |
_c8102969 _d8102969 |